Tirzepatide TFA
Product Specifications
Target
Glucagon Receptor
Related Pathways
GPCR/G Protein
Bioactivity
Tirzepatide TFA (LY3298176 TFA), a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, is under development for type 2 diabetes treatment [1].
Molecular Formula
C227H349F3N48O70
Molecular Weight
4927.47
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog